You should not take Doxepin if you take: Know the medicines you take
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial
90 Multimorbidity is common in CKD and obesity with patients typically navigating a healthcare system that is complex, fragmented and siloed
Tirzepatide offers dual agonist activity, targeting both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which may enhance weight loss efficacy compared to single-receptor agonists
Some patients may benefit from slower dose escalation or temporary dose reduction of their GLP-1 medication if constipation becomes problematic, though this should only occur under medical supervision